Pirat Bahar, Muderrisoglu Haldun, Unal Muge Tecder, Ozdemir Handan, Yildirir Aylin, Yucel Muammer, Turkoglu Suna
Department of Cardiology, Baskent University Faculty of Medicine, Ankara, Turkey.
Coron Artery Dis. 2007 Feb;18(1):61-6. doi: 10.1097/MCA.0b013e328010a44a.
Myocardial apoptosis is recognized as a major mechanism of cell death during ischemia-reperfusion. In this study, we assessed the hypothesis that activated protein C may have a cardioprotective effect via preventing apoptosis in a rat model of myocardial ischemia-reperfusion.
Thirty male Sprague-Dawley rats were anesthetized, instrumented for hemodynamic measurements and ventilated mechanically. Twenty rats were subjected to 20 min of left anterior descending coronary artery occlusion and 2 h of reperfusion. They were randomly assigned to receive intravenous Ringer lactate (vehicle) or activated protein C (2 mg/kg/h) 10 min after occlusion and during reperfusion. The other 10 rats were sham-operated. At the end of the reperfusion period, serum samples were obtained for evaluation of creatine kinase, C-reactive protein and tumor necrosis factor-alpha. Apoptosis was measured quantitatively by the terminal deoxynucleotide transferase-mediated dUTP nick-end labeling method.
Serum creatine kinase, C-reactive protein and tumor necrosis factor-alpha values and percentage of terminal deoxynucleotide transferase-mediated dUTP nick-end labeling- positive myocyte nuclei demonstrated negligible myocardial injury in sham-operated controls. During reperfusion, mean arterial pressures were significantly higher in activated protein C-treated rats than in the control group (68.2+/-10.3 vs. 55.4+/-11.6 mmHg, P=0.01). Number of apoptotic cells was significantly reduced from 47.7 to 24.8% with activated protein C administration (P=0.008). No difference was seen between activated protein C-treated and untreated animals with respect to creatine kinase, C-reactive protein and tumor necrosis factor-alpha levels.
Treatment with activated protein C significantly improved hemodynamics after ischemia-reperfusion and reduced ischemia-reperfusion-induced myocardial apoptosis in rats.
心肌细胞凋亡被认为是缺血再灌注期间细胞死亡的主要机制。在本研究中,我们评估了活化蛋白C可能通过预防大鼠心肌缺血再灌注模型中的细胞凋亡而具有心脏保护作用这一假说。
30只雄性Sprague-Dawley大鼠麻醉后,安装用于血流动力学测量的仪器并进行机械通气。20只大鼠接受左前降支冠状动脉闭塞20分钟及再灌注2小时。它们在闭塞后10分钟及再灌注期间被随机分配接受静脉注射乳酸林格液(载体)或活化蛋白C(2mg/kg/h)。另外10只大鼠进行假手术。在再灌注期结束时,获取血清样本以评估肌酸激酶、C反应蛋白和肿瘤坏死因子-α。通过末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法对细胞凋亡进行定量测量。
在假手术对照组中,血清肌酸激酶、C反应蛋白和肿瘤坏死因子-α值以及末端脱氧核苷酸转移酶介导的dUTP缺口末端标记阳性心肌细胞核百分比显示心肌损伤可忽略不计。在再灌注期间,活化蛋白C治疗的大鼠平均动脉压显著高于对照组(68.2±10.3对55.4±11.6mmHg,P=0.01)。给予活化蛋白C后,凋亡细胞数量从47.7%显著减少至24.8%(P=0.008)。在肌酸激酶、C反应蛋白和肿瘤坏死因子-α水平方面,活化蛋白C治疗组和未治疗组动物之间未见差异。
活化蛋白C治疗可显著改善缺血再灌注后的血流动力学,并减少大鼠缺血再灌注诱导的心肌细胞凋亡。